Prenetics Global Limited Class A Ordinary Share 2026 Q2 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Prenetics reported Q2 2026 total revenue of $46.5 million, up 29% sequentially and 3.9 times year over year, with IM8 contributing $45 million at 65% gross margins.
- July 2026 was the strongest month in company history, with $20.9 million revenue and 47,373 new customers acquired at a customer acquisition cost (CAC) of $239, down 21% from Q2.
- The company crossed into positive consolidated adjusted free cash flow in July 2026 for the first time in its history.
- Prenetics ended Q2 2026 with 140,000 active subscribers, 87% of revenue recurring, and 50% of subscribers with at least three months tenure.
- Gross profit for Q2 was $30.2 million at 65% margin, operating costs were $8.8 million (19% of sales), and contribution profit was $21.4 million (46% of sales).
- Marketing spend was $36.2 million (78% of sales), with brand loyalty royalties at 3.5% of revenue and ambassador costs at 4% of revenue.
- Adjusted EBITDA loss for Q2 was $19 million, net loss was $9 million or $0.52 per share, down 45% from prior year.
- General Catalyst committed $1 billion growth financing to fund 70% of acquisition marketing spend, enabling accelerated growth and positive cash flow.
- Prenetics has 15.2 million shares outstanding and 19.2 million fully diluted shares including warrants.
- The company operates an AI-native organization of about 70 employees, delivering high revenue per employee and reducing operating expenses by 21% quarter over quarter.
- Prenetics is present in 46 countries, with China and India as notable markets not yet entered.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Thank you, Shannon. Good morning, everyone. Before anything else, thank you so much for being here. This is actually the first live earnings video webcast we have done in our company's history. From the numbers that are joining right now, it may be the largest group of our shareholders ever gathered in one place. So whether you manage a fund, hold a single share, or are simply here because you drink the sachet every morning, welcome. This is for you. Here is why we are doing it this way. Our shareholders range from global institutions to people who found IM8 as customers and became shareholders. We believe every one of them deserves the same depth of information at the same moment. This moment, we have opened the book to everyone at once. We can do that for a simple reason.
We now have 20 months of data, every cohort, every month, every market measured end to end. Enough history that numbers no longer need my adjectives. I will say this plainly, I do not know of another company, publicly traded or private, that has shown its business in this level of detail in which we are showing you today. I just released a 40-page shareholder letter written to be read, not skimmed. An additional 80-page investor deck that shows you this business the way I see it internally. Every single cohort, every vintage, our full acquisition cost month by month, and even independent cart data measuring our retention against every single brand in our category. In this stream, you hear from us directly. Feel free to ask us anything at the end of this call. A business compounding this fast deserves to be examined, not summarized.
When the numbers are this good, transparency is a weapon. The day that numbers softened, someday you will read it from us first in that letter. One promise I want to make in the next half hour is I am not going to be standing here and just reading you that letter. However, hopefully everyone here listening in can read it later today. What I owe you is a part of the document that cannot do the story of what actually happened, how a brand that did not exist two Decembers ago crossed last month a line most consumer companies never reach. But before I talk a single number, I want to show everyone what we are building first. We made this video, two minutes.
Please enjoy. Prenetics is the parent company of IM8.
Talk to us a little bit about what IM8 is.
We created this supplement. Create nutrition simple.
IM8 just covers everything in one sachet.
What are you willing to do to be the best?
We're very strategic in the businesses that we go into. I don't know whether any of you know about IM8, but you should get IM8 because it's got 92 ingredients.
Is that your secret, IM8?
That's my secret, IM8. You don't have to take 15 or 18 tablets every single morning.
It's just easy, and it's so good for you and the longevity of your life.
I look forward to this every single morning. It's actually my incentive to drink more fluids because I just don't really enjoy it unless I mix that IM8 in it.
Since the moment that I took IM8, man, I've been feeling incredible.
IM8 gives me that immunity and strength that I can wake up every morning and feel good and perform well.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
10 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
